Jafar Amani

22PUBLICATIONS
50CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 23, 2026
CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder.

|Nov 29, 2025
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains.

Shima Aghaei, Mohammad Hossein Yadegari, Masoumeh Rajabibazl

|Jul 28, 2025
Evaluation of Antimicrobial Activity of Novel Chimeric M-PEX12 Peptide Against Acinetobacter baumannii.

Yasin Rakhshani, Hamideh Mahmoodzadeh Hosseini, Seyed Ali Mirhosseini

|Jul 28, 2025
Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study.

Atefeh Faraz, Jafar Amani, Sedigheh Arbabian

|Dec 28, 2024
Design and Cytotoxicity Evaluation of a Cancer-targeting Immunotoxin Based on a Camelid Nanobody-PE Fusion Protein.

Mona Khoshbakht, Mohammad Mahdi Forghanifard, Hossein Aghamollaei

|Oct 13, 2024
In silico and in vitro evaluation of a PE38 and Nb-based recombinant immunotoxin targeting the GRP78 receptor in cancer cells.

Mona Khoshbakht, Mohammad Mahdi Forghanifard, Hossein Aghamollaei

Pageof 4

Frequent Collaborators

3 joint publications

Hamideh Mahmoodzadeh Hosseini

2 joint publications

Milad Gholami

2 joint publications

Iman Salahshourifar

2 joint publications

Shohreh Zare Karizi